The diterpenoid adenanthin upregulates the expression of natural killer group 2D receptor ligands in hepatocellular carcinoma cells

被引:0
|
作者
Zhong, Xiaoming [1 ]
Liao, Hongqun [1 ]
Hu, Shaowen [3 ]
Luo, Kaiyuan [1 ,2 ]
Zhu, Huifang [1 ,2 ]
机构
[1] First Affiliated Hosp Gannan Med Univ, Neonatal Intens Care Unit, Ganzhou 341400, Peoples R China
[2] First Affiliated Hosp Gannan Med Univ, Childrens Med Ctr, Childrens Med Res Inst, Ganzhou 341400, Peoples R China
[3] Gannan Med Univ, Coll Basic Med, Ganzhou 341400, Peoples R China
基金
中国国家自然科学基金;
关键词
Adenanthin; NK cells; NKG2D ligands; Cytotoxicity; Immunotherapy; IMMUNO-ONCOLOGY; NKG2D LIGANDS; NK CELLS; PEROXIREDOXIN; SURVIVAL; CANCER; ROLES; CHAIN;
D O I
10.1016/j.mcp.2021.101759
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Objective: The natural killer (NK) group 2D (NKG2D) receptor plays a crucial role in NK cell-mediated anti-tumor immunity. NKG2D anti-proliferative effect is mediated by direct interactions of the receptor with its ligands that may be considered as a potential target for NK-based immunotherapeutic strategy in cancer cells. Methods: Here we report that a natural product adenanthin significantly promotes NKG2D ligands expression in hepatoma cells. The effect was determined using flow cytometry analysis. The activity of NK cell was evaluated by measuring its degranulation activity and cytotoxicity. Results: Our data indicates that the induction of NKG2D ligand binding to liver cancer cell surface receptors greatly improves the killing activity of NK cells against the cancer cells. Conclusions: This is the first report of a new mechanism anti-cancer effects of adenanthin mediated by an indirect activation of NK cells. Our data suggests that adenanthin may be used to sensitize NK cells in tumor immunotherapy.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Natural killer group 2D receptor and its ligands in cancer immune escape
    Duan, Shixin
    Guo, Weihua
    Xu, Zuxing
    He, Yunbo
    Liang, Chuting
    Mo, Yongzhen
    Wang, Yian
    Xiong, Fang
    Guo, Can
    Li, Yong
    Li, Xiaoling
    Li, Guiyuan
    Zeng, Zhaoyang
    Xiong, Wei
    Wang, Fuyan
    MOLECULAR CANCER, 2019, 18 (1)
  • [2] Expression profiles of Natural Killer Group 2D Ligands (NGK2DLs) in colorectal carcinoma and changes in response to chemotherapeutic agents
    Kucuk, Burak
    Yilmaz, Esra
    Cacan, Ercan
    MOLECULAR BIOLOGY REPORTS, 2021, 48 (05) : 3999 - 4008
  • [3] Expression profiles of Natural Killer Group 2D Ligands (NGK2DLs) in colorectal carcinoma and changes in response to chemotherapeutic agents
    Burak Kucuk
    Esra Yilmaz
    Ercan Cacan
    Molecular Biology Reports, 2021, 48 : 3999 - 4008
  • [4] Clinical-Scale Isolation of Interleukin-2-Stimulated Liver Natural Killer Cells for Treatment of Liver Transplantation With Hepatocellular Carcinoma
    Ohira, Masahiro
    Nishida, Seigo
    Tryphonopoulos, Panagiotis
    Tekin, Akin
    Selvaggi, Gennaro
    Moon, Jang
    Levi, David
    Ricordi, Camillo
    Ishiyama, Kohei
    Tanaka, Yuka
    Ohdan, Hideki
    Tzakis, Andreas G.
    CELL TRANSPLANTATION, 2012, 21 (07) : 1397 - 1406
  • [5] Natural Killer Group 2 Member D, Its Ligands, and Liver Disease: Good or Bad?
    Gao, Bin
    HEPATOLOGY, 2010, 51 (01) : 8 - 11
  • [6] Advancement of chimeric antigen receptor-natural killer cells targeting hepatocellular carcinoma
    Dai, Kai
    Wu, Yin
    She, Sha
    Zhang, Qian
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 13 (12) : 2029 - 2037
  • [7] Exploiting natural killer group 2D receptors for CAR T-cell therapy
    Demoulin, Benjamin
    Cook, W. James
    Murad, Joana
    Graber, David J.
    Sentman, Marie-Louise
    Lonez, Caroline
    Gilham, David E.
    Sentman, Charles L.
    Agaugue, Sophie
    FUTURE ONCOLOGY, 2017, 13 (18) : 1593 - 1605
  • [8] Natural Killer Group 2, Member D/NKG2D Ligands in Hematopoietic Cell Transplantation
    Carapito, Raphael
    Aouadi, Ismail
    Ilias, Wassila
    Bahram, Seiamak
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [9] HBsAg stimulates NKG2D receptor expression on natural killer cells and inhibits hepatitis C virus replication
    Wang, Xiao-Xiao
    Pan, Xiao-Ben
    Han, Jin-Chao
    Cong, Xu
    Jin, Qian
    Kong, Xiang-Sha
    Wei, Lai
    Feng, Bo
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2018, 17 (03) : 233 - 240
  • [10] Peripheral Foxp3+ regulatory T cells and natural killer group 2, member D expression levels in natural killer cells of patients with colorectal cancer
    Shen, Yajuan
    Wang, Qian
    Qi, Yuanying
    Cui, Bin
    Zhang, Zhifen
    Su, Jingran
    Liu, Xiaowen
    Lu, Chao
    Ye, Hui
    Ju, Ying
    Lu, Zhiming
    MOLECULAR MEDICINE REPORTS, 2014, 10 (02) : 977 - 982